Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Severe acute respiratory syndrome coronavirus type 1 (SARS-C...

Class:IdSummation:9704656
_displayNameSevere acute respiratory syndrome coronavirus type 1 (SARS-C...
_timestamp2021-01-27 01:40:26
created[InstanceEdit:9704665] Shamovsky, Veronica, 2020-10-10
literatureReference[LiteratureReference:9704670] Bcl-xL inhibits T-cell apoptosis induced by expression of SARS coronavirus E protein in the absence of growth factors
[LiteratureReference:9704674] Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
[LiteratureReference:9704654] T cell responses in patients with COVID-19
modified[InstanceEdit:9704696] Shamovsky, Veronica, 2020-10-10
[InstanceEdit:9710680] Shamovsky, Veronica, 2021-01-05
[InstanceEdit:9713615] Shamovsky, Veronica, 2021-01-27
textSevere acute respiratory syndrome coronavirus type 1 (SARS-CoV-1) E protein induced apoptosis upon expression in the human Jurkat T-cells in the absence of growth factors (Yang Y et al. 2005). Overexpressed anti-apoptotic Bcl-2-like protein 1 (BCL2L1, also known as BCLX, Bcl-xL) inhibited T-cell apoptosis induced by SARS-CoV-1. BCL2L1 was found to interact with the viral E protein via the BH3 domain of BCL2L1 and a BH3-like domain of E protein. SARS-CoV-1 E protein is thought to induce apoptosis by sequestering anti-apoptotic BCL2L1 to membranes of the endoplasmic reticulum (ER) and Golgi, where the viral E protein is located (Yang Y et al. 2005). High levels of expression of pro‑apoptotic molecules may contribute to the depletion of T lymphocytes by apoptosis, leading to the lymphopenia observed in severely affected SARS patients (Diao B et al. 2020; Chen Z & Wherry EJ 2020).
(summation)[Reaction:9704655] SARS-CoV-1 E binds BCL2L1 [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Severe acute respiratory syndrome coronavirus type 1 (SARS-C... (9704656)